triazoles has been researched along with fg-4592 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Block, GA; Fishbane, S; Locatelli, F; Macdougall, IC | 1 |
| Gupta, N; Wish, JB | 1 |
| De Wilde, L; Deventer, K; Roels, K; Van Eenoo, P | 1 |
| Jensen, BL | 1 |
2 review(s) available for triazoles and fg-4592
| Article | Year |
|---|---|
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients.
Topics: Anemia; Animals; Barbiturates; Blood Pressure; Disease Models, Animal; Drug Design; Drug Interactions; Glycine; Hepcidins; Humans; Hypoxia-Inducible Factor 1; Inflammation; Isoquinolines; Kidney Failure, Chronic; Picolinic Acids; Protein Domains; Pyrazoles; Triazoles | 2017 |
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD.
Topics: Anemia; Barbiturates; Clinical Trials as Topic; Enzyme Inhibitors; Erythropoietin; Glycine; Humans; Hypoxia-Inducible Factor-Proline Dioxygenases; Isoquinolines; Pyrazoles; Renal Insufficiency, Chronic; Triazoles | 2017 |
2 other study(ies) available for triazoles and fg-4592
| Article | Year |
|---|---|
Automated sample preparation for the detection and confirmation of hypoxia-inducible factor stabilizers in urine.
Topics: Chromatography, Liquid; Doping in Sports; Glycine; Humans; Hypoxia-Inducible Factor 1; Isoquinolines; Limit of Detection; Linear Models; Pyrazoles; Reproducibility of Results; Solid Phase Extraction; Substance Abuse Detection; Tandem Mass Spectrometry; Triazoles | 2021 |
Get use to the -dustats: Roxadustat and molidustat, members of the hypoxia-inducible factor (HIF) prolyl hydroxylase (PHD) inhibitor drug class promote kidney function, perfusion and oxygenation in rats through nitric oxide.
Topics: Animals; Glycine; Hypoxia; Isoquinolines; Kidney; Nitric Oxide; Perfusion; Pharmaceutical Preparations; Prolyl Hydroxylases; Prolyl-Hydroxylase Inhibitors; Pyrazoles; Rats; Triazoles | 2021 |